High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. (Q44700029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

title

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Lisa M DeAngelis

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

3

Nina Paleologos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

21

J Gregory Cairncross

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1

Lauren E Abrey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

author name string

Barrett H Childs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Lynne Kaminer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Steven Rosenfeld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Donna Salzman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Jonathan L Finlay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Kendra Peterson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Wendy Hu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Lode Swinnen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Robert Bayer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Peter Forsyth

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Douglas Stewart

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Anne M Smith

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

David R Macdonald

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Susan Weaver

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

David A Ramsey

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Stephen D Nimer

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

16 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

page(s)

127-134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/b:neon.0000003645.82791.2a

16 November 2019

exact match

0 references

cites work

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

12 December 2020

Low-grade oligodendroglioma responds to chemotherapy.

1 reference

12 December 2020

Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas

1 reference

12 December 2020

The role of postoperative irradiation in the treatment of oligodendroglioma.

1 reference

12 December 2020

Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke

1 reference

12 December 2020

Salvage chemotherapy for oligodendroglioma.

1 reference

12 December 2020

Myeloablative chemotherapy for recurrent aggressive oligodendroglioma

1 reference

12 December 2020

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

12 December 2020

Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma

1 reference

12 December 2020

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

1 reference

12 December 2020

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

12 December 2020

Oligodendroglioma: incidence and biological behavior in a defined population

1 reference

12 December 2020

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.

1 reference

12 December 2020

Chemotherapy for oligodendroglioma. Progress report

1 reference

12 December 2020

10.1023/B:NEON.0000003645.82791.2A

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14686732%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 November 2019

1014558581

0 references

Fatcat ID

release_xfifhhmmkjd23hqci4wqrld5aa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfifhhmmkjd23hqci4wqrld5aa

24 November 2022

mapped directly with Wikidata item

1 reference